- €4.72bn
- €18.78bn
- €1.27bn
- 40
- 64
- 94
- 76
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,228 | 985 | 1,004 | 1,175 | 1,273 |
Cost of Revenue | |||||
Gross Profit | 985 | 805 | 823 | 933 | 974 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | -573 | 228 | -475 | 365 | 2,958 |
Operating Profit | 1,801 | 756 | 1,480 | 810 | -1,685 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,399 | 453 | 1,463 | 1,286 | -2,110 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,262 | 392 | 1,294 | 1,148 | -1,903 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 747 | 360 | 924 | 621 | -1,419 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 747 | 360 | 924 | 621 | -1,419 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 8.53 | 3.85 | 9.69 | 6.57 | -14.3 |
Dividends per Share |